Abvc Biopharma (ABVC) Gross Margin Growth (1y) (2018 - 2025)
Abvc Biopharma (ABVC) Gross Margin Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 228.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -475.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,672.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1,034.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20,832.00 |
| Sep 30, 2025 | -19,992.00 |
| Dec 31, 2024 | 642,984.00 |
| Sep 30, 2024 | 18,636.00 |
| Jun 30, 2024 | 119,449.00 |
| Mar 31, 2024 | 2,397.00 |
| Dec 31, 2023 | -638,478.00 |
| Sep 30, 2023 | -16,103.00 |
| Jun 30, 2023 | -119,197.00 |
| Mar 31, 2023 | -3,957.00 |
| Dec 31, 2022 | 4,462.00 |
| Sep 30, 2022 | -2,501.00 |
| Jun 30, 2022 | -62.00 |
| Mar 31, 2022 | -692.00 |
| Dec 31, 2021 | -8,663.00 |
| Sep 30, 2021 | 706.00 |
| Jun 30, 2021 | -18.00 |
| Mar 31, 2021 | 455.00 |
| Dec 31, 2020 | -57.00 |
| Sep 30, 2020 | -604.00 |